In the dynamic world of pharmaceuticals, ensuring patient safety is paramount. Pharmacovigilance, the science and activities relating to detecting, assessing, understanding, and preventing adverse effects or any other drug-related problem, plays a critical role in this endeavor. Mivado GlobalPerformance Inc. is a leading provider of comprehensive pharmacovigilance solutions, helping pharmaceutical companies navigate the complexities of
In today’s competitive global market, Canadian businesses face the critical challenge of enhancing productivity to remain competitive and drive growth.1 Mivado GlobalPerformance, a leading process optimization and improvement service provider, offers a comprehensive framework to help Canadian organizations unlock their full potential. Key Productivity Challenges Facing Canadian Businesses The Mivado GlobalPerformance Approach Mivado GlobalPerformance employs
Artificial intelligence (AI) rapidly transforms the biopharmaceutical industry, offering unprecedented opportunities to enhance efficiency, accuracy, and innovation. However, as AI becomes increasingly integrated into GMP-regulated processes, traditional quality management approaches must be rethought. This article delves into the critical aspects of GMP quality compliance in the AI era. It explores the top five reasons why
Good Manufacturing Practice (GMP) quality compliance is a cornerstone of the biopharmaceutical industry, ensuring that products are consistently produced and controlled according to high standards. As artificial intelligence (AI) and machine learning (ML) find increasing applications across the sector, it’s essential to consider how quality management processes need to evolve. Incorporating AI into biopharmaceuticals can
N-nitrosamine impurities, a class of potentially carcinogenic substances, have become a significant concern in the pharmaceutical industry. These compounds can form during the drug manufacturing process or due to degradation.